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Abstract
Background: Infectious laryngotracheitis virus (ILTV; gallid herpesvirus 1) infection causes high mortality and huge
economic losses in the poultry industry. To protect chickens against ILTV infection, chicken-embryo origin (CEO)
and tissue-culture origin (TCO) vaccines have been used. However, the transmission of vaccine ILTV from
vaccinated- to unvaccinated chickens can cause severe respiratory disease. Previously, host cell responses against
virulent ILTV infections were determined by microarray analysis. In this study, a microarray analysis was performed
to understand host-vaccine ILTV interactions at the host gene transcription level.
Results: The 44 K chicken oligo microarrays were used, and the results were compared to those found in virulent
ILTV infection. Total RNAs extracted from vaccine ILTV infected chicken embryo lung cells at 1, 2, 3 and 4 days post
infection (dpi), compared to 0 dpi, were subjected to microarray assay using the two color hybridization method.
Data analysis using JMP Genomics 5.0 and the Ingenuity Pathway Analysis (IPA) program showed that 213
differentially expressed genes could be grouped into a number of functional categories including tissue
development, cellular growth and proliferation, cellular movement, and inflammatory responses. Moreover, 10
possible gene networks were created by the IPA program to show intermolecular connections. Interestingly, of 213
differentially expressed genes, BMP2, C8orf79, F10, and NPY were expressed distinctly in vaccine ILTV infection
when compared to virulent ILTV infection.
Conclusions: Comprehensive knowledge of gene expression and biological functionalities of host factors during
vaccine ILTV infection can provide insight into host cellular defense mechanisms compared to those of virulent
ILTV.
Background
Avian infectious laryngotracheitis virus (ILTV), named
as a Gallid herpesvirus 1, is a member of the Iltovirus
genus, Alphaherpesvirinae subfamily, and Herpesviridae
family. ILTV has a linearized dsDNA genome of
approximately 150 kb in size which contains unique
long (UL) and unique short (US) sequences flanked by
inverted repeat (IR) and terminal repeat (TR) sequences
[1,2]. The genome encodes 80 predicted viral protein
open reading frames (ORFs). ILTV infection causes
respiratory disease symptoms in chickens, pheasants,
partridges, and peafowl [3,4]. Clinical signs include
extension of the neck, gasping, gurgling, rattling, and
coughing of clotted blood [5]. ILTV usually causes a
reduction in egg production and variable mortality ran-
ging from 5 to 70%, and can cause severe economic
losses in the poultry industry [6].
Two types of commercial live attenuated vaccines,
chicken embryo origin (CEO) and tissue culture origin
(TCO), have been widely used to immunize chicken
flocks against ILTV [6,7]. However, it was found that
live vaccines infect the nervous system similarly to viru-
lent ILTV infections, and could possibly induce vaccinal
laryngotracheitis (VLT) by transmission to unvaccinated
birds [8-10]. Moreover, global ILTV outbreaks are
mostly associated with CEO vaccines [11-13] and the
genomic- and antigenic characteristics between virulent
and vaccine ILTV are very similar [6].
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the recent development of a RNA-seq (RNA sequen-
cing) technique using next-generation sequencing, to
analyze comprehensive gene expression in different bio-
logical conditions. Microarrays have been performed
intensively to investigate host gene transcriptional
responses to infection by various viruses such as hepati-
tis C virus (HCV) [14], rice dwarf virus (RDV) [15],
influenza virus [16], herpesvirus saimiri (HVS) [17],
human immunodeficiency virus (HIV) [18,19], Japanese
encephalitis virus (JEV) [20,21], chicken anemia virus
(CAV) [22], human cytomegalovirus (hCMV) [23],
Epstein-Barr virus (EBV) [24], infectious laryngotrachei-
tis virus (ILTV) [25], varicella-zoster virus (VZV) [26],
alphaherpesvirus [27], Marek’s disease virus (MDV) [28],
herpes simplex virus type 1 (HSV-1) [29], even in vac-
cine strains including recombinant flavivirus [30], west
nile/dengue 4 virus [31], and dengue virus [32].
Previously, we studied the differential gene expression
of host responses against virulent ILTV infection in cul-
tured primary chicken embryo lung cells using microar-
ray analysis [25]. To compare and contrast host
responses to infection of vaccine ILTV to those of viru-
lent ILTV infection, primary chicken embryo lung cells
were infected with live attenuated CEO vaccines and
host gene expression during a four day period post
infection was determined using 44 K chicken oligo
microarrays in the present study.
Results and discussion
Profiling of differentially expressed host genes in vaccine
ILTV infection
Primary chicken embryo lung cells at passage 1 were
infected with 3 vaccination doses of a live fowl laryngo-
tracheitis vaccine, which is widely used in the poultry
industry. The infected cells were subjected to analysis
for cytopathic effects and virus infection validation at 1,
2, 3 and 4 days post infection (dpi). Although weak
cytopathic effects (e.g. cell rounding, aggregation and
syncytia) were observed at certain locations of plates at
1 and 2 dpi, infected cells began to recover by 3 dpi,
and no cytopathic effects were observed at 4 dpi (Figure
1A). To verify the infection of vaccine ILTV, the expres-
sion of ILTV viral RNA was determined and genes of
UL35 encoding a small capsid protein and US5 encod-
ing an envelop glycoprotein J (gJ) were shown to pro-
gressively increase their expression post infection
though US5 expression began to be detected from 2 dpi
(Figure 1B).
In the 44 K microarray assay, two approaches to avoid
possible hidden dye effects were used: the use of RNA
Spike-in controls synthesized from the Adenovirus E1A
transcriptomes containing different concentrations of
dye in each set [33] and the dye-swap in two of four
total replicates. No significant dye effects were detected
in all microarray slides (data not shown). Data analysis
using one-way ANOVA with the JMP Genomics 5.0 and
a 2 fold or greater cut off value revealed that 933 genes
were differentially expressed at 4 different dpi time
points following vaccine ILTV infection (Additional file
1). When these 933 differentially expressed genes were
subjected to the bioinformatics study using Ingenuity
Pathways Analysis (IPA, Ingenuity
® Systems, http://
www.ingenuity.com) to generate the gene networks and
functional annotations, 213 genes were recognized as
mapped IDs (functionally known genes) by the IPA pro-
gram (Additional file 2) and subjected to further bioin-
formatics analysis.
Quantitative reverse transcription-PCR (qPCR)
To validate the microarray results, expression of 18 of
the 933 differentially expressed genes was subjected to
qPCR using the same RNA samples as those used in the
microarray, and gene specific primer sets (Tables 1, 2).
Of the 18 genes tested, the expression pattern for 12
genes completely matched the microarray data at four
dpi time points. The expression pattern for the remain-
ing 6 genes also qualitatively matched to microarray
data, though they were not quantitatively matched
(Table 2). With the comparison of the spike-in controls,
qPCR results indicated that the microarray data in this
experiment were valid to determine host gene expres-
sion responses against vaccine ILTV infection.
The gene expression levels of microarray were pre-
sented by log2 fold changes, whereas those of qPCR
were indicated by -ΔΔCt that are comparable to the
log2 fold change values in microarray
Biological functions of differentially expressed genes
Using the IPA program, the subset of 213 mapped genes
were categorized into 75 biologically functional groups,
and the top 20 groups associated with a greatest number
of genes, are shown in Figure 2. The 20 functional
groups are mostly related to tissue development, cellular
growth and proliferation, organismal development, cell
death, cellular development, cellular movement, and
inflammatory responses.
Top 10 differentially expressed genes
Of 213 genes with known functions with mapped IDs,
the top 10 most differentially expressed genes in ILTV
vaccine infection were selected based on differences of
standard deviation (SD) among all four dpi time points
(Figure 3). The 10 most differentially expressed genes
are involved in functions of reduced inflammatory
responses, stimulation of cell proliferation, suppression
of apoptosis, and promotion of cell-to-cell interactions.
The general function and possible roles of these
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outlined in Table 3.
The C1q and tumor necrosis factor related protein 3
[C1QTNF3; also known as (a. k. a.) CTRP3] is known to
s t i m u l a t eE R K 1 / 2a n dp 3 8M A P K[ 5 8 ] .C 1 Q T N F 3
expression was elevated from 2 to 4 dpi (Figure 3). In
addition, cartonectin (an adipokine of the CTRP3
family) helps reduce inflammation by suppressing IL6
and TNF production and NF-B signaling [59-61]. IL6,
one of several cytomegalovirus secreted cytokines,
enhances the survival of endothelial cells by blocking
caspase 3 and caspase 7-mediated apoptosis [62].
CTRP3 could also accelerate embryonic growth and
may contribute to a high feed efficiency phenotype in
broilers [63]. Thus, the continuous increase of CTRP3
expression from 2 to 4 dpi during ILTV vaccine infec-
tion suggests the suppression of cellular factors related
to inflammation and the promotion of cell recovery
after the initial cytopathic effect that was exhibited in
embryonic lung cells on 1dpi.
Aquaporin 5 (AQP5) expression, a water channel pro-
tein and part of the small integral membrane protein
family, was elevated on 1 dpi, but decreased at 2- and 4-
dpi (Figure 3). A deficiency AQP5 was shown to
0 dpi 1 dpi 2 dpi
3 dpi 4 dpi
(A)
(B)
UL35
US5
chGAPDH
0123 4
dpi
Figure 1 Morphology of chicken embryo lung cells infected by vaccine ILTV and the expression of ILTV genes. (A) Cell morphology and
cytopathic effect development at 0, 1, 2, 3 and 4 dpi are displayed by phase-contrast microscopic images at 200 × magnification. (B) ILTV gene
expression for UL35 and US5 was determined by RT-PCR. Chicken GAPDH (chGAPDH) was used as an endogenous control.
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Page 3 of 13exacerbate lung injury by the infection of Pseudomonas
aeruginosa [64]. Down-regulation of AQP5 increases
proliferation and migration of human corneal epithelial
(CEP117) cell line [65]. Adenovirus infection to mouse
lung caused the down-regulation of AQP5 gene
expression [66]. Thus, the slight down-regulation of
AQP5 gene expression in vaccine ILTV infection in
from 2 to 4 dpi may be associated with the reduced
cytopathic effect and cell recovery.
Cholecystokinin (CCK) was down-regulated in lung
cells between 2 and 4 dpi (Figure 3). CCK is a peptide
hormone of the gastrointestinal system that is important
in fat digestion [67]. CCK induces apoptosis by stimulat-
ing death signaling pathways in rat pancreatic acinar
cells, including caspase activation, cytochrome C release,
and mitochondrial depolarization [68]. Thus, the down-
regulation of CCK expression in vaccine ILTV infected
cells may suppress apoptosis, resulting in weak cyto-
pathic effects.
Gene networks
Network analysis by IPA was used to draw connections
between interacting focus molecules. Of the 10 networks
that were generated, the top 4 networks were identical
among all four dpi, which may be due to the fact that
the algorithms of the IPA program generate a network
by considering fold change values and p-values of focus
molecules in addition to their biological functions. The
lists, top functions, and the most focused molecules of
all four networks are shown in Additional file 3, and the
drawings of interacting molecules in each network dur-
ing the time course of all dpi are displayed in Additional
file 4.
The most interactive network (network #1) at 1 dpi is
presented in Figure 4. Similar differential expression
levels for focus molecules in network #1 are shown at
all four dpi during ILTV vaccine infection and the top
f u n c t i o n sr e l a t e dt og e n e si nt h i sn e t w o r ki n c l u d ef r e e
radical scavenging, lipid metabolism, and small molecule
biochemistry. Several secreting proteins such as FIGF
[c-fos induced growth factor; a.k.a vascular endothelial
growth factor D (VEGF-D)], PDGFC (platelet derived
growth factor C), TNFSF15 (tumor necrosis factor
superfamily member 15), and CRH (corticotropin releas-
ing hormone) in network #1 are closely associated with
the activation of the ERK1/2 signaling pathway [69-72].
Additional cellular factors, including MGAT3 (mannosyl
glucosaminyltransferase 3), HS6ST1 (heparin sulfate 6-
O-sulfotransferase 1), and CIRBP (cold inducible RNA
binding protein), that activate ERK 1/2 by increased
phosphorylation are also upregulated in vaccine ILTV
infection [73-75]. These results indicate that the mito-
genic signaling pathway may be activated by increased
phosphorylation of ERK 1/2 in vaccine ILTV infection,
resulting in weak cytopathic effects that facilitate the
recovery of cellular proliferation capabilities of embryo-
nic lung cells during vaccine ILTV infection. In addition,
several enzymatic antioxidants in lung cells that would
reduce cellular oxidative stress included SOD3
Table 1 Primers for qPCR
GenBank Forward Primer Reverse Primer
AB109635 GGCACCAACTTGCTACCACA GCTGCAAGAGCTGCCATTAG
AF505881 CCAGCTACATCTCCCACCTG TCTGTTTGGGCTGGGAGTTC
BX932962 GTACAACCACGTTGGGCAGA CTCTCGCGTTTCCTTTGAGG
BX931297 TTGTGGCCTACCCCAGATGT GGATGGGACTTTCCAGAGCA
BX931599 CTGTTTCCTGACCGCAGTTC AGCACAAACTCCGCCATTTT
BX933478 CCTGTGCAAGGTGTCCAGTG CCCAATGGCCATACAGTTCA
BX933728 GCAAAGCACCATCCCAAATA TAT TGAGGCGCTGACTCCTG
BX933888 CTGGGATCCCTCCAGAGCTA CCATTCACTGGAGCACCAAA
BX935456 CGAGGCCATCAACTTCCTTC TCCACATGACGCACATACCC
BX936211 CCAGCTGTCCTCCTTGGAAT AGGGAGAGGAAGACGTGCTG
CR352775 GGCCTTGAATGACCATCATGT AACAGCAGCAGGAACAGTGC
CR385566 CGCGCTCTACGACTACATGC CTGGGTGGTGATCTCGGTCT
D87992 TGCAGCACTGAGACCTGGAT CAGTTGCTGCGGATGAAGTC
M60853 TTTTGGCTACCAGTCCAGCA TTCGCAAGTGTTCCCCAGTA
M64990 TGCTCCCCTGAGTACTGGAA GCCTCTGTGGGTTCAGGATT
M80584 TCCCACTGAGCAGCTTCTGTA CCAGAGAGATATCCGCAGCA
M87294 GGTGCTGACTTTCGCCTTGT GCCTGGTGATGAGGTTGATG
X87609 CCACCTGAGAAAAGCGACCT ACATCGACCTCTGCCAACCT
Table 2 Validation of gene expression between
microarray and qPCR
GenBank Symbol Fold Change (Microarray/qPCR)
Day 1 Day 2 Day 3 Day 4
BX932962 SLC37A2 1.2/1.3 2.1/2.6 3.3/3.7 3.9/4.5
M60853 THBS2 1.5/1.8 2.0/2.5 2.8/2.8 3.3/3.3
BX933888 C1QTNF3 -0.2/0.1 1.2/2.0 1.9/2.5 2.7/3.4
BX933728 CAPSL 2.3/3.0 2.6/3.7 3.2/4.3 3.5/4.4
BX931297 CYTL1 1.0/1.7 1.4/2.8 2.7/4.2 2.9/4.4
CR352775 ALDOB 0.7/1.1 1.0/1.7 2.1/2.2 2.7/2.5
BX933478 MXRA5 0.8/1.5 1.7/3.0 2.5/3.7 3.0/4.4
BX935456 EGLN3 -2.7/-2.0 -2.3/-1.9 -1.7/-1.4 -1.3/-0.9
BX931599 VIPR2 1.7/2.0 2.3/2.9 2.9/3.6 3.1/5.1
CR385566 CLEC3B 0.2/1.0 0.4/2.2 1.3/2.4 1.4/3.1
M87294 NPY -0.4/-0.3 -0.9/-0.6 -1.5/-0. 9 -1.7/-1.3
M80584 LUM 1.2/1.6 1. 5/2.3 1.9/2.5 2.5/3.2
M64990 PTGS2 -0.6/-0.6 -0.8/-0.3 -0.2/-0.4 0.7/1.2
AB109635 HMGCR 0.4/0.4 0.2/0.6 -0.5/-0.3 -0.9/-0.6
BX936211 TMEM116 0.0/0.0 -0.3/0.3 -0.3/-0.1 -1.3/-0.7
X87609 FST 1.3/1.0 0.6/1.2 0.6/0.6 -0.3/0.2
D87992 ANPEP -0.1/-1.2 -0.5/0.5 -0.6/0.4 -1.4/-0.2
AF505881 SCX 1.1/0.2 1.4/-0.6 1.8/0.1 2.3/-0.6
Lee et al. BMC Genomics 2012, 13:143
http://www.biomedcentral.com/1471-2164/13/143
Page 4 of 13(superoxide dismutase 3, extracellular), GPX7 (glu-
tathione peroxidase 7), and GSTs (glutathione S tran-
ferases; GST-A3, -T1, -A4) were also assigned to
network #1. This up-regulation of these enzymatic anti-
oxidants would serve to protect cells from oxidant-
mediated cell death. These results concur with a pre-
vious report of enhanced endogenous antioxidant pro-
tection during vaccine ILTV infection and attenuation
of cell death [76]. Focus molecules found in network #1
can be summarized by the following functions:
Functional groups
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Figure 2 Functional groups of differentially expressed genes. Out of 75 functional groups, the top 20 groups considered based on gene
number were displayed.
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Page 5 of 13stimulation of various secreting proteins, inhibition of
the cell death pathway, and attenuation of oxidative
stress.
Functional interpretation of other networks is
described in Additional files 3 and 4.
Comparison of host responses of virulent strain and
vaccine ILTV infection
Previously, we reported 273 differentially expressed
chicken genes mapped by the IPA program for virulent
ILTV infection and the analysis of the functions and
molecular networks of these genes [25]. To find host
cellular mechanisms common to both virulent strain
and vaccine ILTV infection, the 213 differentially
expressed genes that responded to vaccine ILTV infec-
tion in the present study were compared to the 273 dif-
ferentially expressed genes found in the previous
virulent ILTV infection study. The results showed that
25 genes overlapped in both virulent strain and vaccine
ILTV infections. Of these 25 genes, 21 showed a similar
differential expression pattern as found in the virulent
ILTV infection at 1 and 3 dpi (the GenBank accession,
gene symbol and gene name are listed in Additional file
5). Interestingly, 4 of 25 genes were regulated in the dis-
tinct direction for expression patterns at 1 or 3 dpi
between virulent and vaccine ILTV in the present study
(see Figure 5). Those genes included bone
morphogenetic protein 2 (BMP2, AY237249), chromo-
some 8 open reading frame 79 (C8orf79, CR390951),
coagulation factor × (F10, D00844), and neuropeptide Y
(NPY, M87294).
Bone morphogenetic proteins (BMPs), as members of
the transforming growth factor beta (TGFb) superfamily,
are involved in various cellular functions including cell
type specification, differentiation, pluripotency, apopto-
sis, proliferation, and tissue morphogenesis [77]. Dereg-
ulation of BMP signaling is also implicated in disease
states including cancer [78]. Though the functional role
of BMP in ILTV infection is unknown, BMPs including
BMP2 were found to mediate herpesviral reactivation
found in the EBV positive cell line [79]. The expression
and secretion of BMP2 was regulated by HIV proteins
in differentiating mesenchymal stem cells [80]. Expres-
sion of BMP2 in both virulent and vaccine ILTV infec-
tions increased at 1dpi and the increased expression
level in vaccine ILTV infection was maintained until
3dpi, while the expression in virulent ILTV was not
changed at 3dpi (Figure 5). The continuous increase of
BMP2 expression during ILTV vaccine infection may
play a homeostatic role in maintaining cellular morphol-
ogy against virus infection.
Neuropeptide Y (NPY) involves multiple cellular
mechanisms related to both virus entry into the central
nervous system (CNS) and virus-induced neurological
-3
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Figure 3 The 10 most differentially expressed genes in ILTV vaccine infection. The blue, red, green and purple bars represent 1 dpi, 2 dpi,
3 dpi, and 4 dpi for vaccine ILTV infections, respectively. Mean ± standard deviation value of log2 fold change among four dpi time points are
indicated under the gene name.
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Page 6 of 13diseases. NPY protects the nervous system from murine
retrovirus-induced neurological disease [81]. The up-
regulation of NPY was observed in both infection and
reactivation of VZV from a latent infection in human
sensory trigeminal and dorsal ganglia, which are both
sensory neurons [82]. It suggests that the up-regulation
of NPY in virulent ILTV infection at 3 dpi may facilitate
the latent infection in the nervous system. In contrast,
the continuous down-regulation of NPY in vaccine
ILTV infection may delay the latent infection to protect
the host from diseases.
The coagulation factor, F10, is highly expressed during
the early phase of SARS (severe acute respiratory
syndrome) corona virus infection in human peripheral
blood mononuclear cells (PBMCs) [83]. Expression of
F10 in vaccine ILTV infections of lung cells increased at
1- and 3dpi, but the expression in virulent ILTV was
not changed significantly at either 1- or 3dpi (Figure 5).
A functional role of increased expression and secretion
of F10 in vaccine herpesvirus infected lung cells has not
been studied to date. The C8orf79 is an ORF region on
chicken chromosome 8, but its function is unknown.
Conclusions
In this study, we examined genome-wide host cellular
transcriptomic changes by vaccine ILTV infection.
Table 3 Functions of the 10 most differentially expressed genes in ILTV vaccine infection
Symbol Functions
C1QTNF3
(CTRP3)
￿ C1q and tumor necrosis factor related protein 3, a. k. a. CTRP3.
￿ Functions are described in the Result and Discussion.
AQP5 ￿ Aquaporin 5, a water channel protein.
￿ Functions are described in the Result and Discussion.
CCK ￿ Cholecystokinin
￿ Functions are described in the Result and Discussion.
SPINK5 ￿ Serine peptidase inhibitor, Kazal type 5 or chicken ovomucoid
￿ Lymph-epithelial Kazal-type-related inhibitor (LEKTI).
￿ Suppresses cellular functions related to inflammation in human primary keratinocytes (HK) [34].
￿ Down-regulation of SPINK5 at all dpi may support the reduced cell death caused by vaccine ILTV infection.
THBS2 ￿ Thrombospondin 2, a potent inhibitor of tumor growth and angiogenesis and a matricellular glycoprotein which mediates cell-to-
cell interaction [35].
￿ Functions in angiogenesis in patients with early-stage non-small cell lung cancer [36], and wound healing and development of
exuberant granulation tissue in horses [37].
￿ Up-regulation of THBS2 in vaccine ILTV infection may function in virus spread in infected cells.
PPIF ￿ Peptidylprolyl isomerase F, one of the peptidyl-prolyl cis-trans isomerase (PPIase) family proteins and a member of the
mitochondrial permeability transition (PT) pore in the inner mitochondrial membrane.
￿ Stimulates the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins
[38,39].
￿ Apoptosis and necrosis of cells were induced by the activation of the PT pore [40-42].
￿ Down-regulation of PPIF genes in vaccine ILTV infection may play a role in cell death and recovery of cells.
VLDVR ￿ Very low density lipoprotein/vitellogenin receptor
￿ Binds to baculovirus surface membrane to inhibit ligand-receptor interaction in viral infection of HeLa cells [43].
￿ The meaning of down-regulation of VLDLR in ILTV vaccine infection in addition to in other herpesvirus infection, is unknown.
NMU ￿ Neuromedin U, a multifunctional neuropeptide
￿ Functions in conditions of pain and stress, the metabolism and homeostasis of feeding and energy in body, inflammatory
diseases, smooth muscle contraction, and the control of blood flow and pressure [44,45].
￿ Induces early-phase inflammation through the degranulation in mast cells in which NMU-R1 is highly expressed [46].
￿ Acts as an inflammatory mediator via the acceleration of IL-6 production in macrophages [47].
￿ Down-regulation of NMU may represent the inhibition of cellular factors associated with inflammation.
ADAM28 ￿ A disintegrin and metalloproteinase (ADAM) domain 28.
￿ Functions in cell-to-cell and cell-to-matrix interaction on the cell surface for cancer cell proliferation, invasion and metastasis
[48,49].
￿ Up-regulated at carcinoma cells and functions the proliferation and progression of human lung and breast cancer cells [50,51].
￿ Acts as an inhibitor against human dental pulp stem cells (HDPSCs) proliferation and an inducer of apoptosis of HDPSCs through
the stimulation of alkaline phosphatase (ALP) secretion and dentin sialophosphoprotein (DSPP) [52].
￿ Degrades Insulin-like growth factor (IGF) binding protein 3 (IGFBP3) [53].
￿ The decreased expression of ADAM28 in vaccine ILTV infection, may suppress the active induction of apoptosis.
FST ￿ Follistatin
￿ Inhibits follicle-stimulating hormone [54].
￿ Binds and neutralizes activin, a paracrine hormone of TGF-b superfamily, which is related to the regulation of cell proliferation,
apoptosis, and carcinogenesis [55,56].
￿ A member of fibrotic and wound healing response genes and cellular proliferation genes and plays a role in muscle growth and
strength in nonhuman primates and liver proliferation. Moreover, the small plaque mutant of VZV down-regulates FST [57].
￿ Up-regulation of FST at early phase (1 dpi) of vaccine ILTV infection may play a role in the initiation of cytopathic effect.
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Page 7 of 13Unlike our previous research on virulent ILTV infection,
the vaccine ILTV infection showed weak cytopathic
effects, cellular morphology recovery after initial cyto-
pathic effects were observed and very little cell death.
Possible molecular interpretations confirmed the sup-
pression of cell death and weak cytopathic effect pro-
duction during vaccine ILTV infection. Four host
cellular genes were significantly modulated by vaccine
<-3 3< 
Cytokine / Growth Factor Drug Chemical / Toxicant
Enzyme
G-protein Coupled Receptor Ion Channel
Kinase
Ligand-dependent Nuclear Receptor
Phosphatase
Peptidase
Transcription Regulator Translation Regulator
Transmembrane Receptor
Transporter
microRNA
Complex / Group
Other
Figure 4 Network #1 at 1dpi. Symbols of functions for each molecule used to generate the molecular network are displayed. The green
indicates down-regulation, while the red depicts up-regulation. White symbols indicate neighboring genes that are functionally associated but
not included in the differentially expressed gene list. The intensity of color represents the average of log2 fold change in a given population. The
numbers below the color change bar denote log2 values. Symbols for each molecule are presented according to molecular functions and type
of interactions.
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Page 8 of 13ILTV infection, and could represent important secreting
regulators to protect cells from cytotoxic damages.
Although host gene expression by vaccine ILTV infec-
tion was determined in a cell culture system and not by
an in vivo vaccination study, the results in this study
provide important insights into differential host cellular
defense mechanisms by regulating host gene expression
response of vaccine ILTV infection to compare those of
virulent ILTV infection.
Methods
Cell culture and vaccine ILTV infection
Primary chicken embryo lung cells were prepared as
previously described [25]. All cell culture reagents were
purchased from Invitrogen Life Technologies (Carlsbad,
CA). Cells were maintained at 37°C in a 5% CO2 incu-
bator in 10 cm culture dishes by passaging every 3-4
days in 10 ml growth medium consisting Dulbecco’s
Modified Eagle Medium (DMEM, 0.45% glucose) plus
10% fetal bovine serum (FBS), 100 units/ml penicillin,
100 μg/ml streptomycin, and 2 mM L-glutamine. A
modified live ILTV commercial vaccine, LT-Blen (Merial
Limited, Duluth, GA), was used to infect the chicken
embryonic lung cells by the amount equal to 3 vaccina-
tion doses. After incubation of infected cells for 1 h
with gentle rocking every 15 min, growth medium was
added to each culture dish. The cells were incubated for
up to 4 days. The protocols used in this study were
approved by both the Institutional Biosafety Committee
(IBC; permit number: 10007) of the University of Arkan-
sas and the Animal and Plant Health Inspection Service
(APHIS; permit number: 102743) of the United States
Department of Agriculture (USDA).
Total RNA extraction
TRIzol reagent (Invitrogen Life Technologies, Carlsbad,
CA) was used to extract total RNA from uninfected- or
vaccine ILTV infected chicken embryonic lung cells from
1 to 4 days post infection (dpi). Total RNA treated by
DNase I (New England BioLabs Inc., Ipswich, MA) was re-
purified by TRIzol reagent and quantified using a Nano-
drop1000 spectrophotometer (Thermo Scientific, Wil-
mington, DE) and qualified quality assessed by agarose gel
(data not shown). To validate vaccine ILTV infection,
expression of UL35 and US5 genes, in addition to chicken
GAPDH (a host gene expression control), were deter-
mined by end-point reverse transcription PCR with gene
specific primers. PCR amplicons were analyzed by agarose
gel electrophoresis and images were obtained using the
GelDoc system (Biorad, Hercules, CA).
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Figure 5 Four differently expressed genes in both virulent strain and vaccine ILTV infections. Relative expression was compared for four
genes between vaccine ILTV infection and that reported for virulent strain ILTV [25]. The blue, red, green and purple bars represent virulent
strain at 1 dpi, virulent strain at 3 dpi, vaccine at 1 dpi, and vaccine at 3 dpi for ILTV infections, respectively.
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Page 9 of 13Probe labeling and microarray hybridization
Initially, 2 μg of total RNA was used to synthesize Cy3
or Cy5 labeled complementary RNA (cRNA) using the
Two Color Microarray Quick Labeling kit (Agilent
Technologies, Palo Alto, CA) following the manufac-
turer’s instructions and as described previously [25]. To
avoid possible dye effects, RNA Spike-in controls, which
were synthesized from the Adenovirus E1A transcrip-
tomes containing different concentrations of dye in each
set [33], were added to RNA samples as Spike-in A for
Cy3 and Spike-in B for Cy5 and mixed with un-infected
control and vaccine ILTV infected samples at each dpi,
respectively. For the additional control of dye effects,
the dyes were swapped in two of four total replicates to
confirm further hidden dye effects. Each 825 ng of Cy3
and Cy5 labeled cRNA probes were co-hybridized on a
4X44K Agilent chicken oligo microarray (array ID:
015068). After washing and drying, the slides were
scanned using a Genepix 4000B scanner (Molecular
Devices Corporation, Sunnyvale, CA) with the tolerance
of saturation at 0.005%.
Microarray data analysis
Background-corrected red and green intensities for each
spot were used in subsequent analyses. Global normali-
zation based on locally weighted linear regression
(LOWESS) was applied to the intensities by removing
effects which arise from undesirable systematic varia-
tions in microarray experiments. The ratio of signal
intensities of corresponding spots to all Spike-ins used
were compared to reference ratios reported previously
[33]. All normalized data were deposited in the Gene
Expression Omnibus (GEO; accession number:
GSE30269). Genes showing both signal to noise ratio
(SNR) of > 3 (meaning foreground signals are three
times greater than background signals), and foreground
intensity of > 100 at all time points were considered as
reliable signals. To identify differentially expressed genes
throughout the four dpi, normalized fold change values
were subjected to statistical analysis by a one-way
ANOVA test in JMP Genomics 5.0 http://www.jmp.
com/software/genomics/ licensed to the Cell and Mole-
cular Biology (CEMB) program of the University of
Arkansas. Low fold change values, which were less than
two fold differences in all four dpi, were not considered
as differential expression. Fold change values represent-
ing differential expression were displayed as log2
conversions.
Quantitative reverse transcription-polymerase Chain
reaction (qPCR)
To verify the microarray data, qPCR was performed
with 18 genes using gene specific primer sets designed
by Primer3 software http://frodo.wi.mit.edu/cgi-bin/
primer3/primer3.cgi, which were synthesized by Inte-
grated DNA Technologies (Coralville, IA). Primer infor-
m a t i o ni ss h o w ni nT a b l e1 .T h r e eμgo ft o t a lR N A ,
which was used for the microarray analysis, was con-
verted to cDNA and qPCR was performed under the
following conditions: 40 cycles of denaturing 95°C for
30 s, annealing at 58 - 62°C for 1 min, extending at 72°
C for 30 s, and finally extending at 72°C for 10 min. A
non-template control (NTC) and an endogenous loading
control (chicken GAPDH) were used for the relative
quantification. The fold change values for the vaccine
ILTV infected groups compared to uninfected control
were determined by the -ΔΔCT method, which is com-
parable to log2 values in microarray [84].
Bioinformatics
The Ingenuity Pathways Analysis (IPA) software version
9.0 (Ingenuity Systems
®; http://www.ingenuity.com) was
used to study biological functions and molecular interac-
tions among differentially expressed genes. IPA analyzes
various bioinformatics tools including functional annota-
tion, clustering, and network discovery based on Ingenu-
i t yK n o w l e d g eB a s e ,w h i c hi st h ec o r et e c h n o l o g yo fa l l
IPA systems and the p-value developed from Right-tailed
Fisher’s exact test were mainly considered to interpret
the interaction and functions of the differentially
expressed genes [85,86]. The network analysis was lim-
ited to 10 networks and 35 molecules in each network to
concentrate on the closest interacting focus molecules
(focus genes = a subset of uploaded significant genes hav-
ing direct interactions with other genes in the database)
within the differentially expressed genes [87].
Additional material
Additional file 1: All 933 differentially expressed genes at four dpi
time points of vaccine ILTV infection. The Agilent ID, GenBank
accession, gene symbol, log2 fold change (FC), mean log2 FC of four dpi,
and their standard deviations (std) are listed.
Additional file 2: All 213 differentially expressed genes collected by
IPA program. The gene expression levels at all time points were
determined by log2 fold change. All gene symbols and gene names
were generated based on the IPA database and confirmed with the
Unigene function of NCBI.
Additional file 3: GenBank accessions, functions, and major focus
molecules in four molecular networks. (A) The top functions of each
network, scores and the number of focus molecules are listed in each
network. (B) GenBank accession numbers and gene symbols used in
network analysis were listed for each network. Focus molecules were
bolded and GenBank accession number were provided for focus
molecules only. (C) The potentially important focus molecules in each
network are listed.
Additional file 4: Four gene networks. Symbols of functions for each
molecules used to generate molecular networks are displayed. (A)
network #1 (B) network #2 (C) network #3 (D) network #4. Enlarged
images for each dpi are attached. The green indicates down-regulation,
while the red depicts up-regulation. Different color intensities represent
levels of log2 fold change in the designated molecule.
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Page 10 of 13Additional file 5: The 21 genes showing a similar expression
pattern in both virulent strain and vaccine ILTV infection.
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